Ion Gresser

Centre National de la Recherche Scientifique — France

Immunology and Microbiology · Life Sciences

68h-index17.7kcitations277works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

interferon and immune responses(76), Cytokine Signaling Pathways and Interactions(68), Immune Cell Function and Interaction(41), Virus-based gene therapy research(39), Immune Response and Inflammation(30)

Publications276 total

Conséquences pathologiques d’un excès d’interféron<i>in vivo</i>
médecine/sciences·2019· 3 citedOpen Access
A Brief Historical Perspective on the Pathological Consequences of Excessive Type I Interferon Exposure In vivo
Journal of Clinical Immunology·2018· 27 citedOpen Access
Similarities and Dissimilarities in the Effects of Tumor Necrosis Factor and Interferon-a/� on Transplantable Tumors and on Suckling Mice
2015
Interferon should be used to prevent and/or treat Ebola virus disease
Biomedicine & Pharmacotherapy·2015· 2 cited
On intuition and the discovery of interferon
Cytokine & Growth Factor Reviews·2014· 6 cited
Selective expression of inhibitory Fcγ receptor by metastatic melanoma impairs tumor susceptibility to IgG‐dependent cellular response
International Journal of Cancer·2008· 35 citedOpen Access
Interferon: An Unfolding Tale
Journal of Interferon & Cytokine Research·2007· 7 cited
Recombinant Human IFN-α Inhibits Cerebral Malaria and Reduces Parasite Burden in Mice
The Journal of Immunology·2007· 79 citedOpen Access
The antitumor effects of interferon: A personal history
Biochimie·2007· 31 cited
Type I IFNs Stimulate Nitric Oxide Production and Resistance to <i>Trypanosoma cruzi</i> Infection
The Journal of Immunology·2006· 57 citedOpen Access
Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency
Nature Genetics·2003· 785 cited
Type I interferons produced by dendritic cells promote their phenotypic and functional activation
Blood·2002· 525 cited
Endogenous type I interferons as a defense against tumors
Cytokine & Growth Factor Reviews·2002· 98 cited
Inhibition of Plasmodium yoelii blood-stage malaria by interferon α through the inhibition of the production of its target cell, the reticulocyte
Blood·2001· 60 cited
Type I Interferons Potently Enhance Humoral Immunity and Can Promote Isotype Switching by Stimulating Dendritic Cells In Vivo
Immunity·2001· 949 citedOpen Access
Historial Perspective: Three Remarkable Teachers
Journal of Interferon & Cytokine Research·2000· 3 cited
Regulation of type 2 nitric oxide synthase by type 1 interferons in macrophages infected withLeishmania major
European Journal of Immunology·2000· 74 cited
Murine interferon-α1 gene-transduced ESb tumor cells are rejected by host-mediated mechanisms despite resistance of the parental tumor to interferon-α/β therapy
Cancer Gene Therapy·1999· 7 cited
Role of Cytokines in GVL (ESb Lymphoma) and GVHD After Adoptive Transfer of Allogeneic T Lymphocytes in Mice
Journal of Interferon & Cytokine Research·1998· 3 cited
Type 1 Interferon (IFNα/β) and Type 2 Nitric Oxide Synthase Regulate the Innate Immune Response to a Protozoan Parasite
Immunity·1998· 370 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

Michaël G. Tovey(11), Chantal Maury(7), Filippo Belardelli(5), Danièle Brouty‐Boyé(5), Marie‐Thérèse Bandu(5), Pernilla Lindahl(4), Patricia Leary(4), F Vignaux(3), Giovanna Schiavoni(2), David F. Tough(2), Magnus Gidlund(2), Anders Örn(2), Hans Wigzell(2), A Senik(2), Persephone Borrow(2), M T Bandu(2), Jaqueline De Maeyer‐Guignard(2), E. De Maeyer(2), M. T. Thomas(2), C. Bourali(2)